Free Trial

OptimizeRx (OPRX) SEC Filings & 10K Form

$7.54
-0.27 (-3.46%)
(As of 09/6/2024 ET)

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
08/15/2024
3:30 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:25 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
4:22 PM
McCarthy Brian Clark (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:45 PM
OptimizeRx (Filer)
Form S-8 POS
06/12/2024
10:41 AM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:47 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
HALAS GUS D (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:49 PM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:50 PM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:46 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:00 AM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
05/15/2024
4:01 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:10 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
8:32 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:34 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:35 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:35 AM
OptimizeRx (Filer)
Form DEF 14A
04/29/2024
7:38 AM
OptimizeRx (Filer)
Form ARS
04/22/2024
7:37 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/22/2024
7:31 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/18/2024
3:30 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:22 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:41 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:15 AM
OptimizeRx (Filer)
Form NT 10-K
03/06/2024
3:19 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:22 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:23 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:24 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:16 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:53 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2024
3:00 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
4:56 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:06 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:19 PM
OptimizeRx (Filer)
Form 8-K/A
12/29/2023
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/13/2023
1:32 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Biden’s Capital Gains Tax to Devastate Savings! (Ad)

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<
11/06/2023
6:15 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
9:49 AM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:06 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
3:31 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
1:18 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OPRX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners